Press release BoxID: 176153 (Fraunhofer Institut für Zelltherapie und Immunologie)
  • Fraunhofer Institut für Zelltherapie und Immunologie
  • Deutscher Platz 5e
  • 04103 Leipzig
  • Contact person
  • Christina Kühn
  • +49 (341) 35536-9322

Key note lectures at the 3rd Fraunhofer Life Science Symposium in Leipzig

(PresseBox) (Leipzig, ) Several top-notch scientists have agreed to participate in the 3rd Fraunhofer Life Science Symposium on October, 24th and 25th, 2008 in Leipzig. These include Prof. Gustav Steinhoff from Rostock, who will speak about the indications for and long term outcomes of cardiac stem cell therapy. Further key note lectures will be given by Prof. Jürgen Hescheler, Prof.Ulrich Dirnagl, Prof. Bodo-Eckehard Strauer, Dr. Brigitte Onteniente and Dr. Bernd Stratmann. They will cover topics from across the field of Ischemia and Regeneration and present their latest findings in front of an international audience. The six sessions focus on cardiac, cerebral and peripheral ischemia as well as the use of stem cells, process development and imaging.

As the scientific program fills up, numerous sponsors for the industry exhibition which will be located in the atrium of the Fraunhofer Institute for Cell Therapy and Immunology, have also voiced their desire to participate. The space for booths is now, fully five months before the event nearly sold out.

Registration is now possible on and the early bird rebate will be available until June, 15th. June 15th is also the deadline for participation in the symposium with a lecture or a poster. Information and submission forms can be found on the stated homepage.

Fraunhofer Institut für Zelltherapie und Immunologie

The Fraunhofer-Gesellschaft undertakes applied research of direct utility to private and public enterprise and of wide benefit to society.

The Fraunhofer-Institute for Immunology and Cell Therapy (IZI) founded in April 2005 is member of the Fraunhofer-Life Sciences Alliance. Its objective being to find solutions to specific problems at the interfaces between medicine, life sciences and engineering for partners active in medicinerelated industries and businesses. The Institute's core competencies are to be found in regenerative medicine, or more precisely in cell-therapeutic methods of regenerating non-functioning tissue and organs through to the biological substitution with tissue cultivated in vitro (tissue engineering). In order for the living organism to accept the tissues without any difficulty, it is necessary to study cellular and immunological defense and control mechanisms and take these into account during process and product development. These core competencies entail a multiplicity of tasks to be solved by new products and processes. The Institute works especially closely with hospital institutions, performing quality tests and clinical studies on their behalf. Additionally it also provides assistance in obtaining manufacturing licenses and certifications.